Anthrax Research Today is a free monthly online journal that collates and summarizes the latest research about Anthrax, including details on bacillus anthracis, contagiousness, exposure, effects.

Volume 2 (2006), Issue 10 (October)

1. Bacteriophage T4 capsid: a unique platform for efficient surface assembly of macromolecular complexes.
   J Mol Biol, 363(2): 577-88. [Abstract] [Full-text]
2. Intra-endosomal membrane traffic.
   Trends Cell Biol, 16(10): 514-21. [Abstract] [Full-text]
3. Evaluation of ProMED-mail as an electronic early warning system for emerging animal diseases: 1996 to 2004.
   J Am Vet Med Assoc, 229(7): 1090-9. [Abstract] [Full-text]
4. Meningoencephalitis due to anthrax: CT and MR findings.
   Pediatr Radiol, 36(11): 1190-3. [Abstract] [Full-text]
5. A urokinase-activated recombinant anthrax toxin is selectively cytotoxic to many human tumor cell types.
   Mol Cancer Ther, 5(10): 2556-62. [Abstract] [Full-text]
6. Secreted neutral metalloproteases of Bacillus anthracis as candidate pathogenic factors.
   J Biol Chem, 281(42): 31408-18. [Abstract] [Full-text]
7. Bacillus anthracis: a multi-faceted role for anthrax lethal toxin in thwarting host immune defenses.
   Int J Biochem Cell Biol, 39(1): 20-4. [Abstract] [Full-text]
8. Single-step purification of recombinant anthrax lethal factor from periplasm of Escherichia coli.
   J Biotechnol, 126(3): 277-285. [Abstract] [Full-text]
9. Multiple vaccine and pyridostigmine bromide interactions in the common marmoset Callithrix jacchus: immunological and endocrinological effects.
   Int Immunopharmacol, 6(12): 1765-79. [Abstract] [Full-text]
10. Development of methods to measure humoral immune responses against selected antigens in the common marmoset (Callithrix jacchus) and the effect of pyridostigmine bromide administration.
    Int Immunopharmacol, 6(12): 1755-64. [Abstract] [Full-text]
11. Production of biopharmaceuticals and vaccines in plants via the chloroplast genome.
    Biotechnol J, 1(10): 1071-1079. [Abstract] [Full-text]
12. Anthrax Toxin Receptor 2-Dependent Lethal Toxin Killing In Vivo.
    PLoS Pathog, 2(10). [Abstract] [Full-text]
13. Anthrax edema factor, voltage-dependent binding to the protective antigen ion channel and comparison to LF binding.
    J Biol Chem, 281(43): 32335-43. [Abstract] [Full-text]
14. Toxin-deficient mutants of Bacillus anthracis are lethal in a murine model for pulmonary anthrax.
    Infect Immun, 74(11): 6067-74. [Abstract] [Full-text]
15. Retrocyclins kill bacilli and germinating spores of Bacillus anthracis and inactivate anthrax lethal toxin.
    J Biol Chem, 281(43): 32755-64. [Abstract] [Full-text]
16. Pharmacokinetic considerations and efficacy of levofloxacin in an inhalational anthrax (postexposure) rhesus monkey model.
    Antimicrob Agents Chemother, 50(11): 3535-42. [Abstract] [Full-text]
17. Search for cyclodextrin-based inhibitors of anthrax toxins: synthesis, structural features, and relative activities.
    Antimicrob Agents Chemother, 50(11): 3740-53. [Abstract] [Full-text]
18. Biological weapons : Development of a matrix to evaluate the threat of biological agents used for bioterrorism.
    Cell Mol Life Sci, 63(19): 2223-8. [Abstract] [Full-text]
19. Biological weapons : Anthrax vaccines: Pasteur to the present.
    Cell Mol Life Sci, 63(19): 2237-48. [Abstract] [Full-text]

© 2005-2008 Anthrax Research Today. All Rights Reserved.